Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
Authors:
- Ronald F van VollenhovenRVRonald F van Vollenhoven
- Pierre GeborekPGPierre Geborek
- Kristina ForslindKFKristina Forslind
- Kristina AlbertssonKAKristina Albertsson
- Sofia ErnestamSESofia Ernestam
- Ingemar F PeterssonIPIngemar F Petersson
- Katerina ChatzidionysiouKCKaterina Chatzidionysiou
- Johan BrattJBJohan Bratt
- 1 May 2012
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 379 (9827) , 1712-1720
Abstract
No abstract availableKeywords
Funding Information
- Reumatikerförbundet
This publication has 27 references indexed in Scilit:
- Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialThe Lancet, 2008
- A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritisArthritis & Rheumatism, 2007
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trialArthritis & Rheumatism, 2004
- Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trialArthritis & Rheumatism, 2003
- Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two‐year, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999
- Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three MedicationsNew England Journal of Medicine, 1996
- Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid ArthritisNew England Journal of Medicine, 1995